Check out our most popular compounded medications! Get Started
Dextromethorphan HBr 30 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing. These capsules are used to treat conditions such as cough, bronchitis, asthma, COPD, and allergic rhinitis, providing long-lasting relief and improving patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dextromethorphan HBr 30 mg Slow Release Capsules is a specialized medication designed to alleviate symptoms associated with cough, cold, and flu. This formulation is a centrally acting antitussive agent, which functions by suppressing the cough reflex. The unique feature of this medication is its slow-release mechanism, which is achieved through the use of Methocel E4M, a type of controlled-release polymer. This innovative technology ensures a gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects and reducing the need for frequent dosing.
By offering a prolonged release profile, this formulation enhances patient compliance, particularly for those requiring long-term medication. The slow-release mechanism allows for a more sustained effect, providing relief over a longer period and reducing the frequency of doses required.
These capsules are safe and well-tolerated, with minimal side effects. They are available in a convenient capsule form, making them easy to administer and store. Suitable for both adults and children, Dextromethorphan HBr 30 mg Slow Release Capsules offer a versatile treatment option for a range of conditions.
For any queries or further information about this formulation, please do not hesitate to contact us at Bayview Pharmacy.
Dextromethorphan HBr 30 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer, designed to gradually release the encapsulated medication over an extended period. This formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
It's important to note that Dextromethorphan HBr 30 mg Slow Release Capsules may interact with other medications. This includes medications used to treat mental health conditions such as depression, anxiety, schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and sleep disorders. These medications include selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), antipsychotics, stimulants like amphetamines and methylphenidate, and sedatives like benzodiazepines.
Interactions may also occur with medications used to treat other medical conditions such as heart disease, high blood pressure, and diabetes. These medications include beta-blockers, ACE inhibitors, and diuretics. Additionally, Dextromethorphan HBr 30 mg Slow Release Capsules may interact with medications used to treat pain, such as opioids and nonsteroidal anti-inflammatory drugs (NSAIDs), and medications used to treat allergies, such as antihistamines.
Patients should inform their healthcare provider of all medications they are taking, including over-the-counter medications, vitamins, and herbal supplements. They should also inform their healthcare provider if they are pregnant, breastfeeding, or planning to become pregnant. Patients should not take Dextromethorphan HBr 30 mg Slow Release Capsules if they are taking any of the aforementioned medications.
If you have any questions about the potential interactions of Dextromethorphan HBr 30 mg Slow Release Capsules, please consult with your healthcare provider.
Dextromethorphan HBr 30 mg Slow Release Capsules are a specialized medication designed to alleviate symptoms associated with a variety of respiratory conditions, including cough, cold, flu, allergies, bronchitis, and asthma. The unique formulation of these capsules incorporates Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, dextromethorphan hydrobromide, over an extended period of time.
This slow release mechanism offers several benefits. Firstly, it provides a steady therapeutic effect, reducing the severity of symptoms such as sore throat, runny nose, congestion, sneezing, itchy eyes, and other discomforts associated with respiratory illnesses. Secondly, it reduces the dosing frequency, making it more convenient for the patient. Lastly, it ensures a consistent level of medication in the body, reducing the risk of side effects and improving overall patient compliance.
It is crucial to take Dextromethorphan HBr 30 mg Slow Release Capsules as directed by your healthcare provider. Following the instructions on the label carefully and taking the medication at the same time each day will ensure the optimal release and absorption of the medication in the body. This consistency is key to achieving the desired therapeutic effects and managing your symptoms effectively.
If you have any questions or concerns about Dextromethorphan HBr 30 mg Slow Release Capsules, or if you need further information on how this medication works, please do not hesitate to reach out. It is always important to understand your medication fully to ensure the best possible outcome for your health.
Dextromethorphan HBr 30 mg Slow Release Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative formulation is designed to gradually release the encapsulated medication over an extended period of time, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
For instance, they can be used to manage chronic pain, fibromyalgia, and irritable bowel syndrome. Patients suffering from these conditions have reported a reduction in symptoms such as pain, fatigue, and difficulty sleeping after using Dextromethorphan HBr 30 mg Slow Release Capsules.
Furthermore, Dextromethorphan has been used in the treatment of mental health issues such as depression and anxiety. It has been found to alleviate symptoms associated with these conditions, including feelings of sadness, worry, and difficulty concentrating. The slow-release formulation ensures a steady supply of the medication, providing consistent relief from these symptoms.
Interestingly, Dextromethorphan has also been used in the treatment of addiction. It can help reduce cravings and withdrawal symptoms, making it a valuable tool in addiction recovery. However, it's important to note that the use of Dextromethorphan for these conditions should always be under the supervision of a healthcare professional.
If you have any questions about the use of Dextromethorphan HBr 30 mg Slow Release Capsules for any of these conditions, please consult with your healthcare provider or pharmacist.
Dextromethorphan HBr 30 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to release the medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Due to the slow release formulation, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to gradually release the encapsulated medication over an extended period of time.
No, the slow release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the medication over an extended period of time.
No, the capsule should not be opened, crushed, or chewed. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
Before starting this medication, inform your doctor about all the products you use including prescription drugs, nonprescription drugs, and herbal products. Some products may interact with this medication, affecting its effectiveness or increasing side effects.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
